• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种导致淀粉样变性的罕见转甲状腺素蛋白变体的基因型-表型相关性

Genotype-Phenotype Correlation of a Rare Transthyretin Variant Causing Amyloidosis.

作者信息

Chaudhary Ammar G, AlReefi Fadi M, Abou Zahr Riad G, Elzeftawy Hossam A, Alghamdi Saleh S, Bushnag Areej A, Al-Maghrabi Jaudah A, Abumansour Iman S

机构信息

Cardiovascular Diseases Department, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia.

Department of Adult Cardiology, Almoosa Specialist Hospital, Alhasa, Saudi Arabia.

出版信息

CJC Open. 2022 Oct 1;4(12):1031-1035. doi: 10.1016/j.cjco.2022.09.005. eCollection 2022 Dec.

DOI:10.1016/j.cjco.2022.09.005
PMID:36562013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9764124/
Abstract

Left ventricular hypertrophy is a common entity with a broad differential diagnosis. We present a case of a middle-aged woman with left ventricular hypertrophy and neuropathy caused by a rare transthyretin variant in the absence of a family history or regional reports of hereditary transthyretin amyloidosis. This report outlines the diagnosis and management of patients with a mixed phenotype of hereditary transthyretin amyloidosis and enriches clinical data supporting the pathogenicity of a rare variant of transthyretin.

摘要

左心室肥厚是一种常见疾病,鉴别诊断范围广泛。我们报告一例中年女性病例,其左心室肥厚和神经病变由一种罕见的转甲状腺素蛋白变异体引起,且无家族病史或遗传性转甲状腺素蛋白淀粉样变性的区域报告。本报告概述了遗传性转甲状腺素蛋白淀粉样变性混合表型患者的诊断和管理,并丰富了支持转甲状腺素蛋白罕见变异体致病性的临床数据。

相似文献

1
Genotype-Phenotype Correlation of a Rare Transthyretin Variant Causing Amyloidosis.一种导致淀粉样变性的罕见转甲状腺素蛋白变体的基因型-表型相关性
CJC Open. 2022 Oct 1;4(12):1031-1035. doi: 10.1016/j.cjco.2022.09.005. eCollection 2022 Dec.
2
Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.与Pro24Ser转甲状腺素蛋白突变相关的遗传性心脏淀粉样变性:一例报告
J Med Case Rep. 2018 Dec 16;12(1):370. doi: 10.1186/s13256-018-1931-5.
3
A rare pathogenic variant identified in a heart transplant recipient with hereditary transthyretin amyloidosis: a case report.在一名患有遗传性转甲状腺素蛋白淀粉样变性的心脏移植受者中鉴定出一种罕见的致病变体:病例报告。
J Yeungnam Med Sci. 2023 Nov;40(Suppl):S98-S104. doi: 10.12701/jyms.2023.00241. Epub 2023 May 30.
4
A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant.一名患有淀粉样前体蛋白缬氨酸122异亮氨酸变异体的老年日本心脏淀粉样变性患者的病例。
J Cardiol Cases. 2020 Jul 29;22(5):221-225. doi: 10.1016/j.jccase.2020.07.010. eCollection 2020 Nov.
5
Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report.一名孟加拉国患者的玻璃体淀粉样变性伴消化道自主神经病变与一种新型转甲状腺素蛋白p.Gly87Arg变异相关:病例报告
J Med Case Rep. 2017 Aug 13;11(1):222. doi: 10.1186/s13256-017-1407-z.
6
A novel variant of transthyretin, 59Thr-->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family.一种与意大利家族常染色体显性遗传性心脏淀粉样变性相关的甲状腺素运载蛋白新变体,59位苏氨酸突变为赖氨酸。
Circulation. 1995 Feb 15;91(4):962-7. doi: 10.1161/01.cir.91.4.962.
7
Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina.阿根廷参考中心的变异转甲状腺素蛋白淀粉样变性的流行病学。
Mol Genet Genomic Med. 2021 Nov;9(11):e1812. doi: 10.1002/mgg3.1812. Epub 2021 Oct 20.
8
Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.由淀粉样前体蛋白转甲状腺素蛋白V122I变体引起的散发性心脏淀粉样变性
Int Heart J. 2019 Nov 30;60(6):1441-1443. doi: 10.1536/ihj.19-134. Epub 2019 Oct 31.
9
Regression of left ventricular hypertrophy after tafamidis therapy in a patient with transthyretin amyloidosis variant.特发性甲状腺素运载蛋白淀粉样变患者接受塔法米迪治疗后左心室肥厚的消退。
J Med Invest. 2022;69(3.4):320-322. doi: 10.2152/jmi.69.320.
10
Hereditary transthyretin amyloidosis: a case report.遗传性转甲状腺素蛋白淀粉样变性:一例报告。
J Med Case Rep. 2022 Jun 25;16(1):248. doi: 10.1186/s13256-022-03437-0.

引用本文的文献

1
Expanding the Genetic and Clinical Spectrum of Hereditary Transthyretin Amyloidosis: The Glu61Ala Variant.扩大遗传性转甲状腺素蛋白淀粉样变性的基因和临床谱:Glu61Ala变异体
J Pers Med. 2025 Feb 6;15(2):61. doi: 10.3390/jpm15020061.

本文引用的文献

1
Case 10-2022: A 78-Year-Old Man with Marked Ventricular Wall Thickening.
N Engl J Med. 2022 Mar 31;386(13):1266-1276. doi: 10.1056/NEJMcpc2201230.
2
Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining.通过数据挖掘,在沙特人群中鉴定出已确定和候选转甲状腺素蛋白淀粉样变变体。
Hum Genomics. 2021 Aug 11;15(1):52. doi: 10.1186/s40246-021-00351-2.
3
Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review.转甲状腺素蛋白淀粉样变心肌病(ATTR-CM)患者延迟诊断和误诊的影响:一项针对性文献综述
Cardiol Ther. 2021 Jun;10(1):141-159. doi: 10.1007/s40119-021-00219-5. Epub 2021 Apr 20.
4
False-Positive Technetium-Pyrophosphate Scintigraphy in Two Patients With Hypertrophic Cardiomyopathy.两名肥厚型心肌病患者的假阳性焦磷酸盐锝闪烁扫描
Circ Heart Fail. 2021 Mar;14(3):e007558. doi: 10.1161/CIRCHEARTFAILURE.120.007558. Epub 2021 Mar 5.
5
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.加拿大心血管学会/加拿大心力衰竭学会关于心脏淀粉样变性患者评估和管理的联合立场声明。
Can J Cardiol. 2020 Mar;36(3):322-334. doi: 10.1016/j.cjca.2019.12.034.
6
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.转甲状腺素蛋白淀粉样心肌病:美国心脏病学会最新临床综述
J Am Coll Cardiol. 2019 Jun 11;73(22):2872-2891. doi: 10.1016/j.jacc.2019.04.003.